Company / Revenue per Share
IRONWOOD PHARMACEUTICALS INC Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.85
FY2025
5-year range
$1.85 / $2.87
FY2021-FY2025
Trend
-29.6%
vs FY2024
Sector context
#92 of 154
Health Care
What the data says
At $1.85, IRONWOOD PHARMACEUTICALS INC's revenue per share ranks #92 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 10 years, ranging from $0.37 in FY2017 to $2.87 in FY2023.
Based on SEC 10-K filings.
1.85 in FY2025 with a 5-year CAGR of -3.4%.
Declined from $2.87 to $1.85 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -8.4%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Sector benchmark
#92 of 154 in Health CareTop 60% of 154This company $1.85 Sector average $10.35
▼
-82.1% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 29.6% year-over-year.
- Ranks #92 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.85 | -29.6% |
| FY2024 | $2.63 | -8.6% |
| FY2023 | $2.87 | +19.6% |
| FY2022 | $2.40 | -6.7% |
| FY2021 | $2.58 | +17.1% |
| FY2020 | $2.20 | -20.7% |
| FY2019 | $2.77 | +46.8% |
| FY2018 | $1.89 | +415.1% |
| FY2017 | $0.37 | -81.7% |
| FY2016 | $2.00 | +55.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026